An atypical case of Noonan syndrome with KRAS mutation diagnosed by targeted exome sequencing
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Noonan syndrome (NS) is a genetic disorder caused by autosomal dominant inheritance and is characterized by a distinctive facial appearance, short stature, chest deformity, and congenital heart disease. In individuals with NS, germline mutations have been identified in several genes involved in the RAS/mitogenactivated protein kinase signal transduction pathway. Because of its clinical and genetic heterogeneity, the conventional diagnostic protocol with Sanger sequencing requires a multistep approach. Therefore, molecular genetic diagnosis using targeted exome sequencing (TES) is considered a less expensive and faster method, particularly for patients who do not fulfill the clinical diagnostic criteria of NS. In this case, the patient showed short stature, dysmorphic facial features suggestive of NS, feeding intolerance, cryptorchidism, and intellectual disability in early childhood. At the age of 16, the patient still showed extreme short stature with delayed puberty and characteristic facial features suggestive of NS. Although the patient had no cardiac problems or chest wall deformities, which are commonly present in NS and are major concerns for patients and clinicians, the patient showed several other characteristic clinical features of NS. Considering the possibility of a genetic disorder, including NS, a molecular genetic study with TES was performed. With TES analysis, we detected a pathogenic variant of c.458A > T in KRAS in this patient with atypical NS phenotype and provided appropriate clinical management and genetic counseling. The application of TES enables accurate molecular diagnosis of patients with nonspecific or atypical features in genetic diseases with several responsible genes, such as NS.
Abstract
Noonan syndrome (NS) is a genetic disorder caused by autosomal dominant inheritance and is characterized by a distinctive facial appearance, short stature, chest deformity, and congenital heart disease. In individuals with NS, germline mutations have been identified in several genes involved in the RAS/mitogenactivated protein kinase signal transduction pathway. Because of its clinical and genetic heterogeneity, the conventional diagnostic protocol with Sanger sequencing requires a multistep approach. Therefore, molecular genetic diagnosis using targeted exome sequencing (TES) is considered a less expensive and faster method, particularly for patients who do not fulfill the clinical diagnostic criteria of NS. In this case, the patient showed short stature, dysmorphic facial features suggestive of NS, feeding intolerance, cryptorchidism, and intellectual disability in early childhood. At the age of 16, the patient still showed extreme short stature with delayed puberty and characteristic facial features suggestive of NS. Although the patient had no cardiac problems or chest wall deformities, which are commonly present in NS and are major concerns for patients and clinicians, the patient showed several other characteristic clinical features of NS. Considering the possibility of a genetic disorder, including NS, a molecular genetic study with TES was performed. With TES analysis, we detected a pathogenic variant of c.458A > T in KRAS in this patient with atypical NS phenotype and provided appropriate clinical management and genetic counseling. The application of TES enables accurate molecular diagnosis of patients with nonspecific or atypical features in genetic diseases with several responsible genes, such as NS.
참고문헌 (19)
- Romano AA, "Noonan syndrome: clinical features, diagnosis, and management guidelines", Pediatrics, 126, pp.746~759 (2010)
- Schubbert S, "Germline KRAS mutations cause Noonan syndrome", Nat Genet, 38, pp.331~336 (2006)
- Ko JM, "PTPN11, SOS1, KRAS, and RAF1 gene analysis, and genotype-phenotype correlation in Korean patients with Noonan syndrome", J Hum Genet, 53, pp.999~1006 (2008)
- van der Burgt I, "Clinical and molecular studies in a large Dutch family with Noonan syndrome", Am J Med Genet, 53, pp.187~191 (1994)
- Allanson JE, "The face of Noonan syndrome: Does phenotype predict genotype", Am J Med Genet A, 152A, pp.1960~1966 (2010)
- Tartaglia M, "Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome", Nat Genet, 29, pp.465~468 (2001)
- Lepri FR, "Diagnosis of Noonan syndrome and related disorders using target next generation sequencing", BMC Med Genet, 15, pp.14~ (2014)
- Aoki Y, "Recent advances in RASopathies", J Hum Genet, 61, pp.33~39 (2016)
- Zenker M, "Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations", J Med Genet, 44, pp.131~135 (2007)
- Lim JS, "Bone mineral density according to age, bone age, and pubertal stages in korean children and adolescents", J Clin Densitom, 13, pp.68~76 (2010)
- Zenker M, "Genotype-phenotype correlations in Noonan syndrome", J Pediatr, 144, pp.368~374 (2004)
- Seaver LH, "ACMG practice guideline: genetic evaluation of short stature", Genet Med, 11, pp.465~470 (2009)
- Dauber A, "Genetic evaluation of short stature", J Clin Endocrinol Metab, 99, pp.3080~3092 (2014)
- Şıklar Z, "Syndromic disorders with short stature", J Clin Res Pediatr Endocrinol, 6, pp.1~8 (2014)
- Lisi EC, "Genetic evaluation of the pediatric patient with hypotonia: perspective from a hypotonia specialty clinic and review of the literature", Dev Med Child Neurol, 53, pp.586~599 (2011)
- Niihori T, "Germline KRAS and BRAF mutations in cardio-faciocutaneous syndrome", Nat Genet, 38, pp.294~296 (2006)
- Shaw AC, "The natural history of Noonan syndrome: a long-term followup study", Arch Dis Child, 92, pp.128~132 (2007)
- George CD, "Abdominal ultrasound in Noonan syndrome: a study of 44 patients", Pediatr Radiol, 23, pp.316~318 (1993)
- 김성우, "KRAS 유전자 변이로 확진된 Noonan 증후군 신생아 1례", Neonatal medicine, 18(2), pp.374~378 (2011), 대한신생아학회